ÀÚÀ½°ÈÅÁ(ARI-JE) , ´ë±¸ÅëÇÕÀÇ·á ¼¼°è ¼±µµ!
¾ç‧Çѹæ ÅëÇÕÀÇ·á¿¡ ´ëÇÑ ¿¬±¸°á°ú¸¦ ¼¼°è ÀÓ»óÀü¹®°¡µé°ú °øÀ¯ÇÏ°í ¹ßÀü ¹æÇâ°ú ±Û·Î¹ú »ê¾÷È ¹æ¾ÈÀ» ³íÀÇÇϱâ À§ÇÑ ÅëÇÕÀÇ·áºÐ¾ß ±¹Á¦Çмú´ëȸÀÎ ¡®±Û·Î¹ú Àӻ󿬱¸ Á¤»óȸÀÇ 2018 (GLOBAL Clinical Research SUMMIT 2018, ÀÌÇÏ GCRS 2018)¡¯À» 7ÀÏ ±¹È¸ÀÇ¿ø ȸ°ü¿¡¼ °³ÃÖÇÑ´Ù. °È¿»ó ±¹È¸ÀÇ¿øÀÌ ÁÖÃÖÇÏ°í ´ë±¸½Ã, º¸°Çº¹ÁöºÎ ÈÄ¿øÇÏ´Â ÅëÇÕÀÇ·á´Â ¾ç¹æ°ú Çѹæ, Áï Çö´ëÀÇÇаú Çѱ¹ ÀüÅëÀÇÇп¡ ´ëÇÑ »óÈ£ÀÌÇظ¦ ¹ÙÅÁÀ¸·Î °øµ¿Ä¡·á¿Í ¿¬±¸ µîÀ» ÁøÇàÇÏ´Â »õ·Î¿î À¯ÇüÀÇ ÀÇ·á¸ðµ¨ÀÌ´Ù. ÇöÀç ¹Ì±¹‧À¯·´ µî Àü ¼¼°è¿¡¼ Æø³Ð°Ô ÁøÇà Áß¿¡ ÀÖÀ¸¸ç ƯÈ÷, ¾Ï°ú °°Àº ³Ä¡º´ÀÇ Ä¡·áÀ²À» ³ôÀÌ°í ȯÀÚ »îÀÇ ÁúÀ» ³ôÀÌ´Â ¡®ÀüÀÎÀû µ¹º½ ü°è¡¯·Î ÃÖ±Ù ´õ¿í °ü½ÉÀÌ È®´ëµÇ°í ÀÖ´Â ºÐ¾ßÀÌ´Ù. ´ë±¸½ÃÀÇ °æ¿ì Àü±¹ ¾î´À ÁöÀÚüº¸´Ù ¾Õ¼ ÅëÇÕÀǷḦ ÀÇ·áºÐ¾ß ƯȻç¾÷À¸·Î À°¼ºÇØ ¿ÔÀ¸¸ç 2015³â Àü±¹ ÃÖÃÊ·Î ¸¸¼º ³Ä¡¼º Áúȯ¿¡ ´ëÇÏ¿© ¾ç¹æ°ú ÇѹæÀ» ÅëÇÕ Áø·áÇÏ´Â ¿¬±¸º´¿øÀÎ ¡®ÅëÇÕÀÇ·áÁøÈï¿ø ÀüÀκ´¿ø¡¯À» °³¼ÒÇß´Ù. ¿ÃÇØ 6¿ù¿¡´Â ¼¼°è ÃÖÃÊ·Î ´ÜÀÏ ¹°ÁúÀÌ ¾Æ´Ñ 10°³ ÀÌ»óÀÇ º¹ÇÕ¹°Áú·Î ±¸¼ºµÈ ÀÚÀ½°ÈÅÁ*À» ¹Ì±¹ ½ÄÇ°ÀǾ౹(US, FDA)ÀÇ ½Å±Ô °Ç°º¸Á¶¼ººÐ(NDI; New Dietary Ingredient)À¸·Î ÀÎÁõ¹Þ´Â µî ¿¬±¸ ¼º°ú¸¦ ¿Ã¸®±âµµ ÇÏ¿´´Ù.
* Âü´ç±Í, ÀÛ¾à, »ýÁöȲ µîÀÇ 12°³ ¾àÃÊ·Î ¸¸µé¾îÁø µ¿ÀǺ¸°¨ ó¹æÀ¸·Î ¸ö¾È¿¡¼ À½±â°¡ ¾àÇÏ¿© ¹ß»ýÇÏ´Â ¿©·¯ Áõ»ó¿¡ È¿°ú, ½ÄÇ°ÀǾàÇ°¾ÈÀüó¿¡ ÁøÇØ°Å´ãÁ¦·Î µîÀçµÇ¾î ÀÖÀ¸¸ç À¯¹æ¾Ï Ç×¾ÏÁ¦(Ÿ¸ñ½ÃÆæ)°ú º´¿ë Åõ¿©ÇßÀ» ¶§ Ä¡·áÈ¿°ú°¡ ³ô´Ù´Â »ç½Ç È®ÀÎ À̹ø Çà»ç¸¦ ÁÖ°üÇÏ°í ÀÖ´Â (Àç)ÅëÇÕÀÇ·áÁøÈï¿øÀº ÀÚÀ½°ÈÅÁÀÌ ¹Ì±¹ ½ÄÇ°ÀǾ౹(US, FDA) NDI ÀÎÁõ ȹµæÇÔÀ¸·Î½á ¹Ì±¹ ¹× ±Û·Î¹ú ÀÇ¡¤ÇÑ¾à º´¿ëÅõ¿© ÀÓ»ó½ÃÇèÀÌ °¡´ÉÇØÁ³À¸¸ç È¿°ú ÀÔÁõÀ» ÅëÇØ ÇÑÀÇÇÐÀÇ ¿ì¼ö¼ºÀ» ¼¼°è¿¡ ¾Ë¸®°í ¼ö¸¹Àº ³Ä¡¼ºÈ¯ÀÚµéÀÇ Ä¡·á¿¡µµ Å« µµ¿òÀÌ µÉ °ÍÀ¸·Î ¸»Çß´Ù. 7ÀÏ, °³ÃֵǴ GCRS 2018¿¡¼´Â ¡¸ÀÚÀ½°ÈÅÁ(ARI-JE) ¹Ì±¹ FDA NDI ½ÂÀÎ : ¼¼°èÃÖÃÊ¡¹ (GREAT SUCCESS : 1st US FDA NDI Approval of ARI-JE)À̶ó´Â ÁÖÁ¦ ¾Æ·¡ Çõ½ÅÀÇ·á, ÷´ÜÀÇ·á, ÅëÇÕÀÇ·á µî ¹ßÀü°ú º¯È¸¦ °ÅµìÇÏ°í ÀÖ´Â º¸°ÇÀÇ·á»ê¾÷¿¡ ´ëÇÏ¿© ¿¬±¸¿¡¼ »ê¾÷ȱîÁö ´Ù°¢Àû Á¢±ÙÀÌ ÀÌ·ç¾îÁö°Ô µÈ´Ù. ±×µ¿¾È ±Û·Î¹ú Çù·ÂÀ» ÅëÇØ ¼öÇàµÈ ÅëÇÕÀÇ·á ¿¬±¸ °á°ú¹°À» ¹Ì±¹ ÇϹöµå´ëÇб³, Á¶ÁöŸ¿î´ëÇб³, Áß±¹ Àå½´ÁßÀÇÇк´¿ø, ¢ß¾Æ¸®¹ÙÀÌ¿À, Á¤¿ìBIT µî°ú °øÀ¯ÇÏ°í, ÅëÇÕÀÇ·áÀÇ È¹±âÀûÀÎ ¹ßÀü°ú ±Û·Î¹ú »ê¾÷ȸ¦ À§ÇÑ SHI (Standardization & Harmonization, Integration) ¹× ±¹³»¿Ü Á¦µµÈ ¹æ¾ÈÀº ¹°·Ð, Àӻ󿬱¸ÀÇ °¡¼ÓÈ ¹× Çõ½Å ¿¬±¸¸ðµ¨ µî¿¡ °üÇÏ¿© ³íÀÇÇÏ°Ô µÈ´Ù. ƯÈ÷, »õ·Î¿î ÀÇ·á±â¼ú (ÀǾàÇ°, ÀÇ·á±â±â, º¹ÇÕÁ¦Á¦ µî)ÀÌ °³¹ßµÇ°í, ÀÌ¿¡ µû¸¥ Àӻ󿬱¸ÀÇ °á°ú´Â ±¹³»¿Ü »ê¾÷È ¹°°áÀ» ÀÏÀ¸Å°´Â °è±â°¡ µÉ °ÍÀ̸ç, ±×¿¡ µû¸¥ ÀÇ·á»ê¾÷°ú ¼ºñ½ºÀÇ ¹ßÀüÀº ±¹¹ÎÀÇ º¹Áö Çâ»ó°ú °æÁ¦ ¹ßÀü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÒ °ÍÀ¸·Î ±â´ëµÈ´Ù. À̹ø ±¹Á¦Çмú´ëȸ´Â ÀÚ¼¼ÇÑ ³»¿ëÀº °ø½Ä ȨÆäÀÌÁöÀÎ ±Û·Î¹ú Àӻ󿬱¸ Á¤»óȸÀÇ 2018(www.global-summit.or.kr)¿¡¼ È®ÀÎÇÒ ¼ö ÀÖ´Ù. ±Û·Î¹ú Àӻ󿬱¸ Á¤»óȸÀÇ 2018 ÇÐȸ ¼¼ºÎÀÏÁ¤2018³â 9¿ù 7ÀÏ(±Ý)Time/ModeratorSession9:30 ~ 10:00µî·Ï Registration10:00 ~ 10:50Moderator: ¹éÁ¤ÇÑ ±³¼ö°³È¸½Ä Opening Ceremony (³»ºóÀλç, Ãà»ç, ȯ¿µ»ç) ☐ ³»ºó¼Ò°³ (VIP Introduction) ☐ °³ ȸ »ç (Opening address) : ¼Õ°ÇÀÍ ÅëÇÕÀÇ·áÁøÈï¿ø ÀÌ»çÀå ☐ ȯ ¿µ »ç (Welcoming address) : °È¿»ó ±¹È¸ÀÇ¿ø ☐ Ãà »ç (Congratulatory address) - Mr. Kang Do Tae : °µµÅ º¸°Çº¹ÁöºÎ º¸°ÇÀÇ·áÁ¤Ã¥½ÇÀå (Head of Department, Ministry of Health and Welfare) - Dr. Stephen Rosenfeld : ½ºÅ×ÆÇ ·ÎÁ¨ÆçÆ® ¹Ì¿¬¹æº¸°Ç¼º, SACHRP ȸÀå (Chair, SACHRP : Dept. of Health and Human Service, USA) - Dr. Robert Clarke : ·Î¹öƮŬ¶ô Á¶ÁöŸ¿î´ëÀÇ·á¿ø ¿¬±¸ÇÐÀå (Dean of Research/ Professor, Georgetown University Medical Center) - Mr. Chang Shin-Ho (Bishop, Daegu Archdiocese) : Àå½ÅÈ£ ´ë±¸´ë±³±¸ º¸ÁÂÁÖ±³ ☐ »çÁøÃÔ¿µ(Photo Time)10:50 ~ 11:00Intermission11:00 ~ 12:00Moderator: ¹éÁ¤ÇÑ ±³¼öÅëÇÕÀÇ·á : ¿¬±¸¿¡¼ »ê¾÷È·ÎÀÇ Ã¹±æÀÌ ¿¸®´Ù - World¡¯s 1st CIM Road Opens : Building the Concrete Global Bridge between R&D and Industrialization - ☐ ¼¼°èÃÖÃÊ US FDA NDI ½ÂÀÎ: ÅëÇÕÀÇ·áÀÇ À§´ëÇÑ °á½Ç : °½Â¿ì ¹Ú»ç (World¡¯s 1st : US FDA NDI Approval of CIM, Great Success - Past, Present, Future -) ☐ ¿¬±¸¿Í »ê¾÷ÈÀÇ ¿¬°á, ±Û·Î¹ú »ê¾÷ȸ¦ À§ÇÑ Àü·« (Building a Concrete Global Bridge between R&D and Industrialization) - »ê¾÷È·Î ¿¬°áµÇ´Â Àӻ󿬱¸¼öÇàÀÇ ÁúÀûµµ¾à ¹æ¾È : ¹Ù¹Ù¶óºñ¾î ±³¼ö (Improving the Performance of Clinical trial for Global directives) - ¼¼°èÃÖÃʼöÇà : ´Ù±¹°¡ ÅëÇÕÀÇ·á ÀÓ»ó½ÃÇèÀÇ Ã¹ ½Ãµµ : ¸®Áöº§ ±³¼ö) (1st Challenge of CIM multi-national clinical trial, USA-China-Korea)12:00 ~ 12:30Panel Chair: À̹«¿ ±³¼öÆгÎÅäÀÇ : Panel Discussion Dr.·ÎÁ¨Æçµå, Dr.¹Ù¹Ù¶óºñ¾î, Dr.¸®Áöº§, Dr.·Î¹öƮŬ¶ô, Dr.¾ß¿Àâ °½Â¿ì ¹Ú»ç, ½ÅÀÓÈñ ±³¼ö, ±è¿ëÈ£ ±³¼ö12:30 ~ 12:40Moderator: ¹éÁ¤ÇÑ ±³¼öÆóȸ½Ä Closing Ceremony ☐ Æó ȸ »ç (Closing Address) : º¯Áؼ® ´ë±¸ÇÑÀÇ´ëÇб³ Àǹ«ºÎÃÑÀå (CEO, Daegu Hanny Univ. Medical Center) 12:40 ~ 13:30Moderator: °û»ó±Ô ±³¼ö ȯ¿µ¿ÀÂù Welcome Lunch (VIP lunch)
|